Guideline Education Program
In 2020, the AGA and the Joint Task Force on Allergy-Immunology Practice Parameters (JTF) published evidence-based recommendations on the clinical management of EoE for pediatric and adult allergists and gastroenterologists [Hirano et al. 2020].
But a 2020 survey conducted among 240 gastroenterologists showed that practice patterns in EoE management differ markedly from consensus guidelines indicating a need for education and guideline dissemination to standardize practice [Eluri et al. 2020]:
- Only 24% (n = 52) were ‘very familiar’ with EoE guidelines
- Just 12% (n = 28) followed EoE diagnosis guidelines
To meet this need for education and guideline dissemination and to address issues of emerging and novel therapies, the AGA launched its EoE Guideline Education program as part of its “EoE: Expand, Optimize, Excel” initiative.
Ikuo Hirano, MD, is chair of the program working with Glenn Furuta, MD, and Nirmala Gonsalves, MD, to develop a training program for trusted, knowledgeable health care professionals in gastroenterology practices and health systems across the country and equip them to educate and support their colleagues in delivering high-quality care for patients with EoE.
At the end of this presentation, learners will be able to:
- Recognize guideline recommended management strategies for EoE
- Discuss latest guideline recommendations in EoE clinical practice
- Discuss emerging therapies and practice changes for EoE management
To claim credit, visit AGA University. You will need to create a free account to log in and claim your credit.
This activity is accredited through Jan. 3, 2022.
The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians. The AGA Institute designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Ikuo Hirano has received research support from Adare/Ellodi, Allakos, Arena, AstraZeneca, Meritage, Celgene/Receptos/BMS, Regeneron/Sanofi, and Shire/Takeda; served as a consultant for Adare/Ellodi, Allakos, Amgen, Arena, AstraZeneca, Celgene/Receptos/BMS, Eli Lilly, EsoCap, Gossamer Bio, Parexel/Calyx, Phathom, Regeneron, Sanofi, and Shire/Takeda.
Glenn T. Furuta has received research support from NIH, Arena, Holoclara; is the founder of EnteroTrack.
Nirmala P. Gonsalves has served as a consultant for Allakos, Astra-Zeneca, Sanofi-Regeneron, Abbvie, Knopp, Takeda; received speaker fees from Takeda and royalties from Up-to-Date.
American Gastroenterological Association
This initiative is supported by independent medical education grants from Takeda Pharmaceuticals USA, Inc.
PRODUCED IN CONJUNCTION WITH KNIGHTEN HEALTH